Answers are grounded in this paper and cite their sources.
Review shows aspirin hinders tumor progression across diverse cancers, highlighting its therapeutic potential alongside chemotherapy and immunotherapy.
• This review summarizes the current research and mechanisms of aspirin in cancer. • In order to clarify the role of aspirin in cancer prevention and treatment, and to elucidate its possible mechanism of action, a retrospective study was conducted to sum up. • It was proved that aspirin showed advantages in immunomodulation, cell metabolism, gene repair, reduction of inflammatory reaction, anti-platelet activation and improvement of intestinal flora. At the same time, the combination of aspirin and existing anti-tumor drugs also showed some synergistic effects. • Collectively, this evidence provides a basis for the use of aspirin as an adjunct to other existing therapies, such as immunotherapy and cytotoxic chemotherapy, for the treatment of cancer progression and metastasis. Aspirin [ 1 ], also known as acetylsalicylic acid, is a common non-steroidal anti-inflammatory drug (NSAID). The available evidence shows that aspirin can effectively prevent and treat diseases such as rectal, gastric, ovarian, prostate, and lung cancer. Aspirin has been extensively studied for the prevention and treatment of colorectal cancer. In recent years, studies have found that the potential mechanism of aspirin in the prevention and treatment of cancer may lie in immune regulation, the role of DNA repair pathways, the regulation of cell metabolism, anti-inflammatory effects and antiplatelet effects.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: